Cargando…

A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development

Background: Investing in the R & D sector of new medical technologies is associated with the risk of being rejected by paying organizations because of the lack of value-for-money. The purpose of this study is to investigate the different methods of evaluating the impacts of emerging medical tech...

Descripción completa

Detalles Bibliográficos
Autores principales: Goudarzi, Zahra, Nikfar, Shekoufeh, Kebriaeezadeh, Abbas, Yousefi Zenouz, Reza, Abdollahi Asl, Akbar, Tavakoli, Nader
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840857/
https://www.ncbi.nlm.nih.gov/pubmed/35321374
http://dx.doi.org/10.47176/mjiri.35.141
_version_ 1784650718281465856
author Goudarzi, Zahra
Nikfar, Shekoufeh
Kebriaeezadeh, Abbas
Yousefi Zenouz, Reza
Abdollahi Asl, Akbar
Tavakoli, Nader
author_facet Goudarzi, Zahra
Nikfar, Shekoufeh
Kebriaeezadeh, Abbas
Yousefi Zenouz, Reza
Abdollahi Asl, Akbar
Tavakoli, Nader
author_sort Goudarzi, Zahra
collection PubMed
description Background: Investing in the R & D sector of new medical technologies is associated with the risk of being rejected by paying organizations because of the lack of value-for-money. The purpose of this study is to investigate the different methods of evaluating the impacts of emerging medical technologies. Methods: Using scoping review method, we analyzed studies that investigated methods for assessing the impacts of emerging medical technologies on development. To find these studies, the Cochran Library, ISI Web of Knowledge, Embase, Ebsco and Pubmed databases from 2000 to 2018 were searched. The methodological quality of the studies was assessed using the STROBE Checklist. Two reviewers independently selected the qualified studies. Charting and collating the data were used based on the method proposed by Arksey and O'Malley. Results: Overall, 38 studies met the inclusion criteria. Sixteen methods were identified and put in five distinct categories: forecasting, Pro-HTA, Early-HTA, priority setting, and HHS were found to measure the impact of emerging technologies. The quality of these studies was acceptable. Few studies were conducted on emerging pharmaceutical technologies, and they were mostly on emerging medical devices. The Early HTA methods were often used to measure the effects of pharmaceutical technologies and medical devices technologies. The Pro-HTA method used dynamic modeling to examine the impact of medical technologies on a broad range of dimensions, while the HTA and Early-HTA methods used cost-effectiveness techniques throughout the development process. The HHS method used a multivariate decision-making technique. Conclusion: Different methods were used to investigate the impacts of emerging medical technologies. Chronologically Pro-HTA methods are new ways for investigating emerging medical technologies beyond clinical and economic impacts. Assessing the feasibility of implementing Pro-HTA in real environments deserves further research.
format Online
Article
Text
id pubmed-8840857
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Iran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-88408572022-03-22 A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development Goudarzi, Zahra Nikfar, Shekoufeh Kebriaeezadeh, Abbas Yousefi Zenouz, Reza Abdollahi Asl, Akbar Tavakoli, Nader Med J Islam Repub Iran Review Article Background: Investing in the R & D sector of new medical technologies is associated with the risk of being rejected by paying organizations because of the lack of value-for-money. The purpose of this study is to investigate the different methods of evaluating the impacts of emerging medical technologies. Methods: Using scoping review method, we analyzed studies that investigated methods for assessing the impacts of emerging medical technologies on development. To find these studies, the Cochran Library, ISI Web of Knowledge, Embase, Ebsco and Pubmed databases from 2000 to 2018 were searched. The methodological quality of the studies was assessed using the STROBE Checklist. Two reviewers independently selected the qualified studies. Charting and collating the data were used based on the method proposed by Arksey and O'Malley. Results: Overall, 38 studies met the inclusion criteria. Sixteen methods were identified and put in five distinct categories: forecasting, Pro-HTA, Early-HTA, priority setting, and HHS were found to measure the impact of emerging technologies. The quality of these studies was acceptable. Few studies were conducted on emerging pharmaceutical technologies, and they were mostly on emerging medical devices. The Early HTA methods were often used to measure the effects of pharmaceutical technologies and medical devices technologies. The Pro-HTA method used dynamic modeling to examine the impact of medical technologies on a broad range of dimensions, while the HTA and Early-HTA methods used cost-effectiveness techniques throughout the development process. The HHS method used a multivariate decision-making technique. Conclusion: Different methods were used to investigate the impacts of emerging medical technologies. Chronologically Pro-HTA methods are new ways for investigating emerging medical technologies beyond clinical and economic impacts. Assessing the feasibility of implementing Pro-HTA in real environments deserves further research. Iran University of Medical Sciences 2021-10-26 /pmc/articles/PMC8840857/ /pubmed/35321374 http://dx.doi.org/10.47176/mjiri.35.141 Text en © 2021 Iran University of Medical Sciences https://creativecommons.org/licenses/by-nc/3.0/This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial-ShareAlike 1.0 License (CC BY-NC-SA 1.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Review Article
Goudarzi, Zahra
Nikfar, Shekoufeh
Kebriaeezadeh, Abbas
Yousefi Zenouz, Reza
Abdollahi Asl, Akbar
Tavakoli, Nader
A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development
title A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development
title_full A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development
title_fullStr A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development
title_full_unstemmed A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development
title_short A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development
title_sort scoping review of different methods of assessing the impact of new medical technologies at early stages of development
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840857/
https://www.ncbi.nlm.nih.gov/pubmed/35321374
http://dx.doi.org/10.47176/mjiri.35.141
work_keys_str_mv AT goudarzizahra ascopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment
AT nikfarshekoufeh ascopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment
AT kebriaeezadehabbas ascopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment
AT yousefizenouzreza ascopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment
AT abdollahiaslakbar ascopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment
AT tavakolinader ascopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment
AT goudarzizahra scopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment
AT nikfarshekoufeh scopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment
AT kebriaeezadehabbas scopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment
AT yousefizenouzreza scopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment
AT abdollahiaslakbar scopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment
AT tavakolinader scopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment